1 / 77

Cholinoceptor activating drugs

Cholinoceptor activating drugs. M.R. Zarrindast. Cholinergic Receptors: Where are they? . Postganglionic parasympathetic neuroeffector junctions All autonomic ganglia At the neuromuscular endplate. Cholinergic Receptors: Types. Muscarinic receptors Nicotinic receptors

darrion
Download Presentation

Cholinoceptor activating drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cholinoceptor activating drugs M.R. Zarrindast

  2. Cholinergic Receptors: Where are they? • Postganglionic parasympathetic neuroeffector junctions • All autonomic ganglia • At the neuromuscular endplate

  3. Cholinergic Receptors: Types • Muscarinic receptors • Nicotinic receptors Based on selective activation and antagonism.

  4. Subtypes and characteristic of cholinoceptors

  5. Muscarinic receptors(Stimulated by muscarine) • on cells innervated by PNS • smooth muscle • heart • exocrine glands • endothelial cells of the vascular beds (even though these are not innervated) • brain

  6. Nicotinic receptors(Stimulated by nicotine) • autonomic ganglia - CNS & PNS • neuromuscular junction (somatic nerves) • brain – esp. the spinal cord

  7. The major groups of cholinoceptor-activating drugs

  8. Cholinergic agonists • Two (2) types • Direct – • occupy and activate receptors • Indirect • inhibit acetylcholinesterase • levels of Ach increase • Ach stimulates receptors

  9. Esters of Choline

  10. Esters of Choline • hydrophilic • differ in breakdown by Ach’esterase • acetylcholine - very susceptable • methacholine - 3X less susceptible • bethanechol - not susceptible • methacholine & bethanechol • longer duration of action than Ach • mostly activate muscarinic receptors

  11. Direct • Esters of choline – mostly activate muscarinic receptors • methacholine • bethanechol • Alkaloids – activate both muscarinic and nicotinic receptors • pilocarpine • nicotine

  12. Properties of choline esters

  13. Alkaloids(pilocarpine and nicotine) • Highly lipid soluble • well absorbed from GI tract • get into brain • Capable of both muscarinic and nicotinic receptor activation

  14. Nicotinic to depolarizing blockade receptors are susceptible • depolarizes ganglion cell or neuromuscular endplate • if present in high concentration, they produce a “depolarizing block” • neuron or endplate stays depolarized • skeletal muscle relaxation • ganglia of both PNS & SNS systems may be paralyzed

  15. Effects of Muscarinic Agonists • Eye • Cardiovascular system • Heart • Blood vessels • Respiratory tract • Gastrointestinal tract

  16. Effect of direct-acting cholinoceptor stimulants

  17. Eye • pupillary sphincter muscle contraction (miosis) • ciliary muscle contraction • opens drainage canals in anterior chamber • lowers intraocular pressure • lens thickens for near vision

  18. CV Effects • Direct effects on heart • decreased SA and AV conduction velocity • decreased force of atrial contraction • Reduced vascular resistance – • activation of receptors on endothelium • generation of nitric oxide (NO) • NO causes vascular muscle relaxation • Effects on BP modified by reflexes

  19. Cardiac Conduction - Ach • Increased K+ conduction – slows conduction • SA node • AV node • Decreased inward Ca++ current – reduces force of contraction • Slowed pacemaker rate opposed by reflexes • Ventricles are less directly affected (parasympathetic innervation of ventricles much less than atria)

  20. Respiratory Effects • bronchial smooth muscle contraction • respiratory gland secretion • asthmatics highly sensitive

  21. GI Effects • Increased secretion • gastric glands • salivary glands • Increased motility - diarrhea

  22. Cholinergic receptors in the brain • Brain has muscarinic receptors • Esters don’t penetrate • Alkaloids penetrate well • Brainstem and spinal cord contain nicotinic receptors • Mild alerting from smoking • Seizures in overdose

  23. Nicotine • Complex effects on receptors • Agonist effects • brain nicotinic receptors • ganglionic nicotinic receptors – turns on both PNS and SNS • neuromuscular nicotinic receptors – only in overdose • Blockade - may produce a “depolarizing block” of nicotinic receptors in high doses

  24. Nicotine • Organ effects • Determined by predominate branch of the autonomic nervous system in that organ • CV effects - largely sympathetic • Increased HR, SV, CO • Vasoconstriction of vascular beds • GI & Urinary - largely parasympathetic • Chronic toxicity is the most serious from a societal point of view

  25. Indirect-Acting Agents • inhibit Ach’esterase • buildup of Ach at ganglia, neuroeffector and neuromuscular junctions • amplify effects of endogenous Ach • chief use: insecticides

  26. Acetylcholinesterase Inhibitors 1. simple alcohols (edrophonium) 2. carbamic acid esters (neostigmine) 3. organophosphates (isoflurophate)

  27. Enzyme Binding • simple alcohols - bind to enzyme reversibly (edrophonium) • carbamates - bond with Ach’ase more long-lasting e.g. 30 mins • organophosphates - bond irreversibly; very long acting

  28. Duration of Action of Cholinesterase Inhibitors • Determined mostly by length of binding to enzyme • simple alcohols - short • carbamates - intermediate • organophosphates - very long

  29. Therapeutic uses and durations of action of cholinesterase inhibitors

  30. Edrophonium (Tensilon) • Short acting alcohol type • Uses • Diagnosis of myasthenia gravis* • Muscle strength tested after administration • Marked improvement is a positive test • Adequacy of treatment *Look up the pathogenesis of myasthenia gravis

  31. Edrophonium (Tensilon) • Test adequacy of treatment with longer acting agents (e.g. pyridostigmine) • Improvement means dose of long acting agent too low • No improvement or worsening indicates “depolarizing block” by long-acting agent. Lower dose indicated.

  32. Organophosphates • phosphorylates Ach’esterase enzyme • covalent phosphorus-enzyme bond strong • After time the bond “ages” or gets stronger • enzyme may be rejuvenated with pralidoxime, esp. before “aging”

  33. Signs and symptoms of organophosphate poisoning

  34. Some Insecticides • Organophosphates • chlorpyrifos (Dursban) • malathion • diazinon • Carbamate • Carbaryl (Sevin)

  35. Cholinesterase Inhibitors • CNS - may cause convulsions • GI, respiratory, urinary – stimulatory, like direct-acting agents

  36. Cholinesterase Inhibitors • Cardiovascular • both sympathetic & parasympathetic stimulation • parasympathetic predominate • bradycardia, decreased CO, modest fall in BP

  37. Cholinesterase Inhibitors • Skeletal muscle • therapeutic doses - • moderately prolong Ach • intensify Ach actions • toxic doses • fibrillation of muscle fibers • depolarizing blockade and muscle paralysis

  38. Clinical Uses of Cholinergic Agonists • Glaucoma – physostigmine once used • GI and urinary stimulation - bethanechol • myasthenia gravis • edrophonium for diagnosis or testing • pyridostigmine for treatment

  39. SLUDGE: Toxicity • Salivation • Lacrimation • Urination • Defecation • Gastric Emptying

  40. Cholinesterase Inhibitor Toxicity • approximately 100 organophosphates & 20 carbamate insecticides available • SLUDGE • convulsions in bad toxicities • depolarizating nmj blockade

  41. Cholinergic Blockers More selective than agonists; may block muscarinic or nicotinic receptors selectively M.R. Zarrindast

  42. Cholinergic Blockers • muscarinic blockers - very useful in medicine • ganglionic blockers - not used much • neuromuscular blockers - used for skeletal muscle relaxation in surgery

More Related